Fujii T, Iwase T, Shen Y, Fukui J, et al. Reconsidering the definition of triple-negative breast cancer in the immune checkpoint inhibitor era: an optimal cut-off value for hormone receptor percentage of HER2-negative invasive breast cancer. Br J Cancer 2025 Oct 18. doi: 10.1038/s41416-025-03197.
PMID: 41109918